Cargando…

Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study

RATIONALE: Most cognitive domains show only minimal improvement following typical or atypical antipsychotic treatments in schizophrenia, and some may even worsen. One domain that may worsen is procedural learning, an implicit memory function relying mainly on the integrity of the fronto-striatal sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Veena, Ettinger, Ulrich, Lee, Seoung Eun, Deuschl, Christine, Anilkumar, Anantha P., Schmechtig, Anne, Corr, Philip J., ffytche, Dominic H., Williams, Steven C. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534487/ https://www.ncbi.nlm.nih.gov/pubmed/25980483 http://dx.doi.org/10.1007/s00213-015-3959-1

Ejemplares similares

A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
por: Shoja Shafti, Saeed, et al.
Publicado: (2014)

Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Effect of olanzapine combined with risperidone in the treatment of schizophrenia and its influence on cognitive function
por: Yang, Lujie, et al.
Publicado: (2021)

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2004)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Insight, distress and coping styles in schizophrenia
por: Cooke, Michael, et al.
Publicado: (2007)

Pituitary volume reduction in schizophrenia following cognitive behavioural therapy
por: Premkumar, Preethi, et al.
Publicado: (2018)

Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learning
por: Ettinger, Ulrich, et al.
Publicado: (2013)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
por: Dilla, Tatiana, et al.
Publicado: (2014)

Uncontrollable voices and their relationship to gating deficits in schizophrenia
por: Kumari, Veena, et al.
Publicado: (2008)

Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2007)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Ye, Wenyu, et al.
Publicado: (2012)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study
por: Rikhari, Praveen, et al.
Publicado: (2022)

Antisaccade performance in schizophrenia: a neural model of decision making in the superior colliculus
por: Cutsuridis, Vassilis, et al.
Publicado: (2014)

A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009)

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
por: García-Cabeza, Ignacio, et al.
Publicado: (2001)

Dorsolateral Prefrontal Cortex Activity Predicts Responsiveness to Cognitive–Behavioral Therapy in Schizophrenia
por: Kumari, Veena, et al.
Publicado: (2009)

Is it me? Verbal self-monitoring neural network and clinical insight in schizophrenia
por: Sapara, Adegboyega, et al.
Publicado: (2015)

Voxel-based magnetic resonance imaging investigation of poor and preserved clinical insight in people with schizophrenia
por: Sapara, Adegboyega, et al.
Publicado: (2016)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Risperidone and Olanzapine Induced Tardive Dyskinesia : A Critical Review of Reported Cases
por: Singh, Gurvinder Pal
Publicado: (2004)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naïve Bipolar Disorder Patients.
por: Gupta, Gajal, et al.
Publicado: (2022)

REEMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Bajaj, Priya, et al.
Publicado: (1999)

Preservation and compensation: The functional neuroanatomy of insight and working memory in schizophrenia()
por: Sapara, Adegboyega, et al.
Publicado: (2014)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

Neural changes following cognitive behaviour therapy for psychosis: a longitudinal study
por: Kumari, Veena, et al.
Publicado: (2011)

The effects of ketamine and risperidone on eye movement control in healthy volunteers
por: Schmechtig, A, et al.
Publicado: (2013)

Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-O-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study
por: Quednow, Boris B., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r2ql5ebajmiosdd8i0acu4k4lm